Moreover, Allo/U15BCAR-NKT cells effectively eliminated BCMA−CD1d− tumor cells through recognition by NKRs such as NKG2D and DNAM-1, confirming an NKR-mediated targeting mechanism (Figures 4D–4F). The gene discussed is CD226; the disease is neoplasm.